Back to Top Skip to main content Skip to sub-navigation

Military Health System participating in COVID-19 vaccine trial

Woman measuring out a vaccine into a needle Five military medical treatment facilities are participating in a Phase 3 clinical trial testing a COVID-19 vaccine in development with AstraZeneca. (Photo by Air Force Staff Sgt. Joshua Garcia.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | Vaccine Trials

Five military medical treatment facilities in the National Capital Region, Texas, and California are participating in a phase 3 clinical trial testing the AstraZeneca COVID-19 vaccine in development under Operation Warp Speed.  The DoD sites are actively enrolling study participants, with a goal to recruit up to 1,000 volunteers in each of the three market areas towards the total AstraZeneca clinical trial enrollment of 30,000 people.

Operation Warp Speed, a multiagency U.S. Government effort led by the Department of Health and Human Services and the Department of Defense, is working with the private sector with the aims to deliver safe and effective COVID-19 vaccine doses to the American public beginning January 2021.

OWS is funding clinical trials evaluating several vaccine candidates which were selected based on promising data on safety, immune response, and protection in animal studies and safety and immune response data in early-stage trials in humans. Each of the trials is designed to collect data on how well a vaccine candidate protects against COVID-19 and on the safety of the vaccine candidate in a larger population, including people most at risk.  

“The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” said Thomas McCaffery, assistant secretary of Defense for Health Affairs. “Now that vaccines have passed the first phases of testing for safety, dosing, and response, we have moved into the next phase where volunteers are needed to join large clinical studies. We are excited to have several sites supporting these next steps in the vaccine development process.”

Large phase 3 clinical trials are a necessary part of the rigorous scientific process to test the efficacy and safety of a vaccine in a real-world setting with a large population sample, said Air Force Col (Dr.) Jessica Cowden, chief medical officer of the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnology Vaccine Acceleration Project.

“Phase 3 studies are designed to evaluate if the vaccine can prevent disease in the populations of people that the vaccine is being developed to protect,” said Cowden. “Phase 3 studies are large and usually involve some people who are at risk for infection and disease.”

The National Institute of Allergy and Infectious Diseases at the National Institutes of Health established a network of infectious disease experts and research partners, termed the Coronavirus Prevention Network, or CoVPN, to rapidly and thoroughly evaluate U.S. government-sponsored COVID-19 vaccines. The CoVPN website (https://www.coronaviruspreventionnetwork.org/) provides general information about products being developed to prevent COVID-19 and about clinical trials.

According to the CoVPN, interested volunteers must be adults aged 18 and older to be screened for these initial trials. The CoVPN recognizes the importance of including volunteers who are more likely to get COVID-19, such as those over the age of 65 or with underlying medical conditions; as well as people who work in an essential job, live in a densely populated area, or represent a racial and ethnic group greatly impacted by the epidemic.

Representation by such groups matters in Phase 3 trials because vaccines need to be tested in populations who are at most risk of being exposed to the disease and getting sick in the real world, explained Cowden. “At-risk populations shouldn’t bear a disproportionate burden of research, but they need to be represented,” she said

The selected DoD sites are currently enrolling volunteers for the AstraZeneca clinical trial, according to Cowden. The trial is a randomized control, double-blind study, meaning volunteers will either receive the study vaccine or saline. “The study team and the participant will be blinded so that they won’t know which the participant received until the end of the study,” Cowden said. AstraZeneca’s vaccine candidate is in late-stage clinical trials ongoing in the U.K., Brazil and South Africa.

“Participating in a vaccine clinical trial is voluntary but is also critically vital to ensure that the overall effort is ultimately successful,” said Dr. Sean Biggerstaff, acting deputy director, DHA Research and Development Directorate. “Volunteers should also know safety remains an overriding priority for anyone participating in clinical trials.”

Military health beneficiaries who wish to volunteer for the AstraZeneca COVID-19 vaccine at a nearby military medical treatment facility (or at a civilian site close to home) can contact the local study team directly to request more information or can register on the CoVPN website and consent to be contacted by a research team. If registering on the CoVPN site, interested volunteers should enter the appropriate code in parenthesis from the list below, or enter their ZIP code to join the registry. Site contact information is included here:

At this point, the DoD is only participating in the AstraZeneca study. Additional DoD sites are being prepared for participation in other clinical trials of vaccines and monoclonal antibodies to prevent COVID-19, said Cowden.

“Having a safe and effective COVID-19 vaccine is what we need to protect people and get life back to normal, but in order to get to that point, we have to do these clinical trials,” explained Cowden. “These big Phase 3 clinical trials with a lot of people participating are critical so we can get the information we need to determine if a vaccine candidate is safe and can prevent COVID-19.”

You also may be interested in...

Vaccines for Teens

Infographic
9/17/2021
Adolescents can get COVID-19. The Pfizer vaccine has been tested for those ages 12-15. Visit www.TRICARE.mil/VaccineAppointments to make an appointment.

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | Vaccine Eligibility

Get to Know the Vaccines

Infographic
9/17/2021
Get to know the vaccines – types of vaccines, how they work and safety monitoring.

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines

Get to know the COVID19 Vaccines

Infographic
9/17/2021
Get to know the vaccines – they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously.

Get to know the vaccines - they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines

After the ventilator COVID survivor advocates for vaccine

Article Around MHS
9/15/2021
Tim Harris is sedated while on a ventilator

Tim Harris, a mobilization and planning specialist, U.S. Army Medical Center of Excellence, is sedated while on a ventilator at Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, Texas, June 27, 2020.

Recommended Content:

Coronavirus

Army Medicine Europe Provides Additional COVID Vaccinations for Immune Compromised

Article Around MHS
9/13/2021
Franz Dietrich, a German local national assigned to Training Support Activity Europe, receives a COVID-19 vaccination at the 7th Army Training Command's (7ATC) Rose Barracks, Vilseck, Germany, May 4, 2021. The U.S. Army Health Clinics at Grafenwoehr and Vilseck conducted a "One Community" COVID-19 vaccine drive May 3-7 to provide thousands of appointments to the 7ATC community of Soldiers, spouses, Department of the Army civilians, veterans and local nationals employed by the U.S. Army. (U.S. Army photo by Markus Rauchenberger)

Army medical treatment facilities in Europe are now offering an additional dose of COVID vaccine for immune compromised beneficiaries.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

The COVID-19 Pandemic: How Health Care Workers are Coping

Article
9/13/2021
a nurse helping a COVID-19 patient

For health care providers, experiencing the pandemic inside a hospital has brought

Recommended Content:

Coronavirus | Military Health Podcasts

Increased COVID Restrictions on the Pentagon Reservation

Article
9/8/2021
Military personnel wearing a face mask

Due to the increase in COVID-19 cases and positive test cases in the National Capital Region, the Pentagon Reservation will move to Health Protection Condition Bravo Plus (Bravo+)

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus

Digital health innovation emerges during COVID-19 pandemic

Article
8/31/2021
The Defense Health Agency’s Connected Health Branch was there to support, advise and deliver new health innovations throughout the pandemic. (Graphic courtesy of DHA Connected Health)

The DHA's Connected Health Branch was there to support, advise, and deliver new health innovations throughout the pandemic.

Recommended Content:

Connected Health | Coronavirus

As Fitness Tests Resume, Troops Seek Post-COVID Exercise Routines

Article
8/31/2021
Military personnel physically training

Keeping fit during pandemic proves hard for some.

Recommended Content:

Total Body Preventive Health and Total Force Fitness | Total Force Fitness | Physical Fitness | Coronavirus

COVID-19 Booster Shots

Infographic
8/27/2021
If you have an immune system that is moderately to severely compromised, the CDC recommends you may receive an additional dose of mRNA COVID-19 vaccine (Pfizer or Moderna). This would be at least 4 weeks after your second dose.

If you have an immune system that is moderately to severely compromised, the CDC recommends you may receive an additional dose of mRNA COVID-19 vaccine (Pfizer or Moderna). This would be at least 4 weeks after your second dose.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility | Coronavirus | COVID-19 Vaccine Efforts

Secretary of Defense Mandates COVID-19 Vaccinations for Service Members

Article
8/26/2021
An Army medic administers the COVID-19 vaccine to another soldier.

Secretary of Defense Lloyd J. Austin III yesterday issued a memorandum directing mandatory COVID-19 vaccinations for service members.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

DOD Intends to Mandate Pfizer Vaccine, Pentagon Official Says

Article
8/25/2021
Pentagon Press Secretary John F. Kirby holds a press briefing, at the Pentagon, Washington, D.C.

Kirby said the health of DOD's military and civilian employees, families and communities is a top priority.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Maintaining Mission Readiness During a Pandemic

Article
8/24/2021
Gen. Place presents at HIMSS in Las Vegas.

DHA Director Army Lt. Gen. (Dr.) Ronald Place discussed the national security implications of the COVID-19 outbreak.

Recommended Content:

Coronavirus | Heroes Behind the Mask | Deployment Health

CSM Gragg Vaccine Statement

Video
8/24/2021
CSM Gragg speaks about COVID-19

CSM Gragg shares his personal story dealing with COVID and the loss associated with it and urges all to take precautions.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | Getting the COVID-19 Vaccine

LTG Place on Vaccine Importance

Video
8/17/2021
LTG Place on Vaccine Importance

LTG Place presents his concerns over those who are still unvaccinated during these unprecedented times. Take the right steps to prevent tragedy befalling your family and schedule your vaccine today at https://tricare.mil/vaccineappointments.

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 42

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.